top of page
SPOTLIGHT
TRENDING
Mesoblast Shows Strong Ryoncil™ Results, Eyes Adult Trial Expansion
Australian biotech company Mesoblast Ltd (ASX: MSB, Nasdaq: MESO) has released encouraging new data for its cell therapy Ryoncil™ (remestemcel‑L), used to treat steroid-refractory acute graft-versus-host disease (SR‑aGvHD). The update was presented at the 2026 Tandem Meetings of the American Society for Transplantation and Cellular Therapy (ASTCT) and the Centre for Blood and Marrow Transplant Research (CIBMTR) in Utah. Key Clinical Findings The real-world data show high sur
1 day ago2 min read
Daily Dispatch
Join our email list and get our free daily newsletter- Mullet Dispatch.
Latest News
Uber and WeRide Launch Commercial Robotaxi Service in the Middle East
Ride-hailing giant Uber Technologies, Inc. and autonomous vehicle leader WeRide have officially launched one of the Middle East’s first commercial robotaxi services, marking a significant milestone for autonomous mobility in the region. Downtown Abu Dhabi Goes Driverless Starting today, WeRide-powered autonomous vehicles are operating in downtown Abu Dhabi, covering key areas such as the Corniche waterfront, Sheikh Zayed Grand Mosque, Khalifa City, Masdar City, and Rabdan. Re
1 day ago2 min read
Mesoblast Shows Strong Ryoncil™ Results, Eyes Adult Trial Expansion
Australian biotech company Mesoblast Ltd (ASX: MSB, Nasdaq: MESO) has released encouraging new data for its cell therapy Ryoncil™ (remestemcel‑L), used to treat steroid-refractory acute graft-versus-host disease (SR‑aGvHD). The update was presented at the 2026 Tandem Meetings of the American Society for Transplantation and Cellular Therapy (ASTCT) and the Centre for Blood and Marrow Transplant Research (CIBMTR) in Utah. Key Clinical Findings The real-world data show high sur
1 day ago2 min read
Seres Therapeutics Shifts Strategy, Pauses Key Trial Investment and Extends Cash Runway
Seres Therapeutics, Inc. (Nasdaq: MCRB), a clinical‑stage company specialising in live biotherapeutics, today announced a significant strategic shift in its development priorities and operations following its latest corporate review. The move comes amid rising costs in late‑stage clinical development and the company’s efforts to maintain financial flexibility into the second half of 2026. Pause on SER‑155 Phase 2 Investment Seres confirmed that, after progressing key start‑u
1 day ago2 min read
U.S. Markets Set to Open Higher After Strong Jobs Data
U.S. equity futures are signalling a higher open on Thursday as Wall Street reacts to a stronger-than-expected January jobs report and key corporate earnings, setting the tone for another active trading session. Major futures tied to the Dow Jones Industrial Average, S&P 500 and Nasdaq 100 are all modestly higher in early trading — up roughly 0.3% across the board — after a choppy prior session that saw the major benchmarks finish near unchanged. Economic Drivers: Jobs & F
1 day ago2 min read
The Powell Investigation and What It Means for Markets in 2026
In January 2026, the United States entered uncharted financial territory: the Department of Justice (DOJ) launched a criminal investigation into Federal Reserve Chair Jerome Powell, a sitting central banker — a move widely described as unprecedented. The probe has triggered intense political debate, divided public opinion, and nervous price action across global markets. What started as scrutiny over Powell’s congressional testimony about a costly $2.5 billion Federal Reserve
Jan 143 min read
Explore more
Top Financial Stories
Categories
bottom of page